JPS59141519A - 制ガン作用を有する蛋白質 - Google Patents

制ガン作用を有する蛋白質

Info

Publication number
JPS59141519A
JPS59141519A JP58015290A JP1529083A JPS59141519A JP S59141519 A JPS59141519 A JP S59141519A JP 58015290 A JP58015290 A JP 58015290A JP 1529083 A JP1529083 A JP 1529083A JP S59141519 A JPS59141519 A JP S59141519A
Authority
JP
Japan
Prior art keywords
protein
cells
substance
cell
antitumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58015290A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0341478B2 (2
Inventor
Kimikazu Itaya
板谷　公和
Kiyoshi Ishii
石井　清士
Kazutaka Mizuta
水田　和孝
Hideo Kaneda
秀夫 金田
Toshiaki Shigenaga
重永　敏明
Kenichi Kujira
鯨　健市
Kazuya Yamanishi
山西　一也
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP58015290A priority Critical patent/JPS59141519A/ja
Priority to EP19840900640 priority patent/EP0134247A4/en
Priority to PCT/JP1984/000019 priority patent/WO1984002912A1/ja
Publication of JPS59141519A publication Critical patent/JPS59141519A/ja
Publication of JPH0341478B2 publication Critical patent/JPH0341478B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP58015290A 1983-01-31 1983-01-31 制ガン作用を有する蛋白質 Granted JPS59141519A (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP58015290A JPS59141519A (ja) 1983-01-31 1983-01-31 制ガン作用を有する蛋白質
EP19840900640 EP0134247A4 (en) 1983-01-31 1984-01-26 PROTEIN WITH ONCOSTATIC EFFECT, PREPARATION METHOD THEREOF, AND ONCOSTATIC MEDICENT CONTAINING THE SAME.
PCT/JP1984/000019 WO1984002912A1 (fr) 1983-01-31 1984-01-26 Proteine a effet oncostatique, son procede de preparation et mediament oncostatique la contenant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58015290A JPS59141519A (ja) 1983-01-31 1983-01-31 制ガン作用を有する蛋白質

Publications (2)

Publication Number Publication Date
JPS59141519A true JPS59141519A (ja) 1984-08-14
JPH0341478B2 JPH0341478B2 (2) 1991-06-24

Family

ID=11884707

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58015290A Granted JPS59141519A (ja) 1983-01-31 1983-01-31 制ガン作用を有する蛋白質

Country Status (3)

Country Link
EP (1) EP0134247A4 (2)
JP (1) JPS59141519A (2)
WO (1) WO1984002912A1 (2)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62115278A (ja) * 1985-09-13 1987-05-26 アンステイテユ・パストウ−ル ヒトクラス２組織適合抗原を欠く細胞系の利用方法
WO2020090372A1 (ja) * 2018-10-30 2020-05-07 兼房株式会社 回転工具

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60112718A (ja) * 1983-11-21 1985-06-19 Kyorin Pharmaceut Co Ltd 抗腫瘍作用を示す蛋白性物質及びその製造方法
JPS60243018A (ja) * 1984-05-17 1985-12-03 Yamanouchi Pharmaceut Co Ltd ヒト内来性癌制御因子
JPS6124520A (ja) * 1984-07-12 1986-02-03 Takeshi Makitsubo 腫瘍壊死因子様物質を抽出する方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0764744B2 (ja) * 1981-11-21 1995-07-12 株式会社林原生物化学研究所 標的細胞障害性因子とヒトインタ−フェロンとを有効成分として含有する悪性腫瘍治療剤
JPS58146293A (ja) * 1982-02-26 1983-08-31 Mochida Pharmaceut Co Ltd 抗腫瘍性糖蛋白質の製造方法
JPS58148826A (ja) * 1982-02-26 1983-09-05 Mochida Pharmaceut Co Ltd 糖蛋白質および腫瘍治療剤
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin
CA1265444A (en) * 1983-06-27 1990-02-06 Lloyd J. Old Effect of human tumor necrosis factor and human interferon on human cancer cells and methods
JPS60112718A (ja) * 1983-11-21 1985-06-19 Kyorin Pharmaceut Co Ltd 抗腫瘍作用を示す蛋白性物質及びその製造方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62115278A (ja) * 1985-09-13 1987-05-26 アンステイテユ・パストウ−ル ヒトクラス２組織適合抗原を欠く細胞系の利用方法
WO2020090372A1 (ja) * 2018-10-30 2020-05-07 兼房株式会社 回転工具

Also Published As

Publication number Publication date
WO1984002912A1 (fr) 1984-08-02
EP0134247A4 (en) 1987-03-05
JPH0341478B2 (2) 1991-06-24
EP0134247A1 (en) 1985-03-20

Similar Documents

Publication Publication Date Title
EP0212501B1 (en) Therapeutic agent for treating hematopoietic diseases
CA1199579A (en) Process for the purification of physiologically active substance having antitumor activity
FI72143C (fi) Foerfarande foer framstaellning av maenniskointerferon.
JPS5896025A (ja) 新規生理活性物質ｃｈ−１およびその製造法
EP0132125B1 (en) A protein having antitumor activity
US4234570A (en) Proteinic active substances
JPH0539305A (ja) アストラガルス・メンブラナセウスから抽出した免疫 変調性多糖類及びこれらを含有する薬剤組成物
JPS59141519A (ja) 制ガン作用を有する蛋白質
CN101167755B (zh) 具有抗肿瘤活性的蜈蚣多糖蛋白复合物的制备方法及用途
JPS58141785A (ja) 抗腫瘍物質の製法
JPS6019720A (ja) ヒト内来性癌制御因子およびその製造法
JPS6137730A (ja) 制ガン作用を有する蛋白質
NO850152L (no) Fremgangsmaate ved fremstilling av human, endogen cancerregulerende faktor.
JPH0379602A (ja) 免疫刺激・抗増殖作用を有する多糖類、その製造方法及びこの物質を含有した薬剤
EP0125892B1 (en) Islets-activating protein derivatives
JPH0251440B2 (2)
JPS608226A (ja) 低分子蛋白質を有効成分とする制ガン剤
JPS62258324A (ja) 制ガン作用を有する糖蛋白質
GB2042558A (en) Interferon inducers, methods for their preparation, pharmaceutical compositions containing them and their use as medicaments
JPH0251439B2 (2)
JPS6122021A (ja) 抗腫瘍性多糖体ｎｒｐ−１およびその製造法
GB2125046A (en) Human leucocyte pepsin like enzyme
US3655875A (en) Clam extract effective against sarcoma 180 and krebs-2 carcinoma in mice
JPS59118716A (ja) 制ガン作用を有する低分子蛋白質
KR890004692B1 (ko) 항종양 생리학적 활성물질의 정제방법